← Open Payments lookup

LORA LONIDIER: Open Payments

NPI 1235210170 · JACKSON, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,519 in 73 payments from 15 companies in 2025. Trend: 2023 $642 · 2024 $1,171 · 2025 $1,519

Food & beverage: $1,419Education: $100
CompanyPaymentsAmount
Mallinckrodt Hospital Products Inc.11$324
AstraZeneca Pharmaceuticals LP14$259
Verona Pharma, Inc.12$174
Boehringer Ingelheim Pharmaceuticals, Inc.8$150
Regeneron Healthcare Solutions, Inc.5$142
GENZYME CORPORATION5$114
Merck Sharp & Dohme LLC4$64
Takeda Pharmaceuticals U.S.A., Inc.3$54
United Therapeutics Corporation2$53
ANI Pharmaceuticals, Inc.2$52

Products named: ACTHAR, DUPIXENT, Ohtuvayre, FASENRA, TEZSPIRE, ZERBAXA, OFEV, GLASSIA.

Industry payments across MS — which companies pay providers there.